Philip Cheng

Philip Cheng


Email [email protected]​

Phone +86 21 6122 3800

Fax +86 21 6122 3899

LanguagesEnglish, Cantonese, Mandarin

Practice groupCorporate & Finance

'Philip Cheng is 'an expert with a depth and breadth of experience' and is 'extremely responsive and makes himself very available'.

Chambers Asia Pacific 2015

Phil Cheng is our fixer in Shanghai; large corporate reorganizations; joint venture strategies; navigating data protection rules; difficult employee terminations. These are the things that people have gone to him for.

He started as a China corporate practitioner focusing on M&A and FDI in 1999, before the legal services market expanded under WTO. These days, he does much more, handling some of the most entrenched issues for household names and international businesses within the region.

Phil walks Western enterprises through the legal and commercial landscape during the entire life-cycle of their investments and dealings in China. Many of his sector areas of focus are heavily regulated-- pharmaceuticals, medical devices, chemicals, industrial products, automotive, and hospitality.

He is the person you want in strategy sessions, crisis situations and where difficult judgment calls need to be made.

He is listed as a Leading Individual in the Employment practice by Chambers Asia Pacific and IFLR 1000 and is also recommended for Corporate and M&A in China by Legal 500 Asia Pacific.

Awards and recognitions


Employment: PRC Law (International Firms)
Chambers Asia-Pacific

Recommended for China: Corporate M&A
Asia-Pacific Legal 500

Leading individual in Employment practice
Chambers Asia and IFLR 1000

Education and admissions


J.D., University of California, Los Angeles School of Law, 2000

B.A., Pomona College, 1994

Bar admissions and qualifications


Representative experience

Advising one of the world's largest private companies on the massive corporate restructuring of its newly acquired businesses throughout China and Asia.

Advising world-leading medical device and technology enterprise in its 'go-to-market' strategy in China and subsequent establishment of distribution facilities in Shanghai.

Advising NYSE-listed technology company on strategic alliance with Chinese railway on development of new-generation energy storage devices for the China market.

Acting for a German heavy equipment manufacturer on a labour strike in Shanghai involving more than 300 workers and handling subsequent employee breaches of restrictive covenants.

Acting for a U.S. Fortune 500 financial services company on the roll-out of its entire employment program in China and on operational matters since establishment of its data center.

Advising international materials handling manufacturer on two-year shareholder dispute and divestiture of its interests in a joint venture in Zhejiang.

Advising leading household name in pharma and consumer health products on the divestiture of several consumer brands throughout Asia and the acquisition of orthopedics business in China.

Advising one of the world's largest medical testing companies in its China consolidation through a combination of statutory merger and asset transfer arrangements.

Advising top pharma multinational on the termination of high-level executives for fraud and potential corrupt practices involving concertive actions with hospital administrations, vendors and other employees.

Advising U.S. conglomerate on the build-out of its petro-chemicals facilities and resolving corporate structuring, financing, permit and licensing, vendor contracting, construction, employment and IP protection issues.

Advising U.S. data company on data protection issues arising from the sourcing and collection of information within China and handling the shut-down and termination of certain marketing businesses and staff.

Loading data